Endometrial cancer is the most common type of gynecologic cancer in developed countries.
1,2 Between 2% and 5% of all endometrial cancer cases are associated with a hereditary susceptibility to cancer, mainly Lynch syndrome,
3 which is an autosomal dominant disorder caused by a germline mutation in one of the DNA mismatch repair (MMR) genes
MLH1 (RefSeq NM_000249),
MSH2 (RefSeq NM_000251),
MSH6 (RefSeq NM_000179),
PMS2 (RefSeq NM_000535), and
EPCAM (RefSeq NM_000535).
4 Although estimates vary, the incidence of Lynch syndrome may be as high as 1 in 370 in the general population in the United States.
5 Depending on the mutated gene, cumulative risk of developing endometrial cancer by age 70 years for women is thought to be between 15% and 30%.
6-8 Apart from hysterectomy, there is no consensus recommendation for reducing endometrial cancer risk for women with an MMR gene mutation.
9,10